Copyright
©The Author(s) 2023.
World J Cardiol. May 26, 2023; 15(5): 262-272
Published online May 26, 2023. doi: 10.4330/wjc.v15.i5.262
Published online May 26, 2023. doi: 10.4330/wjc.v15.i5.262
aTRH (No) | aTRH (Yes) | |||||
HR | (95%CI) | HR | (95%CI) | HR (95%CI) by sex | ||
Sex | Female | Reference | 1.67 | (1.45, 1.91) | 1.64 (1.43, 1.88) | |
Male | 1.25 | (1.16, 1.34) | 1.39 | (1.12, 1.56) | 1.13 (1.01, 1.27) | |
HR (95%CI) (M vs F) | 1.25 | (1.16, 1.35) | 0.80 | (0.66, 0.97) | ||
RERI (95%CI) | -0.52 | (-0.75, 0.25) | ||||
Interaction of sex and aTRH on CVD: P < 0.0001 | ||||||
HR (95%CI) by age | ||||||
Age | < 65 | Reference | 1.56 | (1.42, 1.71) | 1.53 (1.32, 1.77) | |
≥ 65 | 1.38 | (1.31, 1.45) | 1.61 | (1.48, 1.73) | 1.18 (1.05, 1.32) | |
≥ 65 vs < 65 | 1.37 | (1.28, 1.47) | 1.05 | (0.87, 1.27) | ||
RERI (95%CI) | -0.339 | (-0.61, 0.06) | ||||
Interaction of age and aTRH on CVD: P = 0.0326 |
- Citation: Nelson JT, Liu L. Pharmacoepidemiologic study of association between apparent treatment resistant hypertension, cardiovascular disease and interaction effect by sex and age. World J Cardiol 2023; 15(5): 262-272
- URL: https://www.wjgnet.com/1949-8462/full/v15/i5/262.htm
- DOI: https://dx.doi.org/10.4330/wjc.v15.i5.262